Skip to main content

Table 3 Diagnostic performance of DNA methylation-based biomarkers in cohort #1

From: Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients

Parameters Panel #1 Panel #2
Sensitivity % 97.3 100.0
Specificity % 80.0 100.0
Positive predictive value % 96.0 100.0
Negative predictive value % 85.7 100.0
Accuracy % 94.4 100.0
Positive likelihood ratio (LR+) 4.87
Negative likelihood ratio (LR−) 0.03